HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Recent advances with a virosomal hepatitis A vaccine.

AbstractBACKGROUND:
Epaxal, a virosomal vaccine against hepatitis A virus (HAV) infection, has been in use for nearly 15 years, especially among at-risk adults. Recent studies have shown that it is also a potent vaccine for children.
OBJECTIVE:
To summarise recent advances of Epaxal Junior (0.25 ml, paediatric formulation).
METHODS:
Published papers reporting results on the virosomal HAV vaccine were abstracted and reviewed.
RESULTS/CONCLUSION:
In a comparative randomised trial, the paediatric dose was found to be highly immunogenic and non-inferior to the standard dose with respect to seroprotection rates. The concomitant administration of virosomal HAV vaccine with routine childhood vaccines was investigated in another trial. The virosomal HAV vaccine did not interact with the antibody response of routine childhood vaccines which in turn did not reduce the antibody response to HAV. In countries that recommend immunisation against hepatitis A, this virosomal vaccine is an excellent candidate with few side effects at the site of injection.
AuthorsPatrick A Bovier
JournalExpert opinion on biological therapy (Expert Opin Biol Ther) Vol. 8 Issue 8 Pg. 1177-85 (Aug 2008) ISSN: 1744-7682 [Electronic] England
PMID18613769 (Publication Type: Journal Article)
Chemical References
  • Hepatitis A Antibodies
  • Hepatitis A Vaccines
  • Virosomes
  • epaxal berna
Topics
  • Child
  • Child, Preschool
  • Health Services Needs and Demand
  • Hepatitis A (prevention & control)
  • Hepatitis A Antibodies (biosynthesis)
  • Hepatitis A Vaccines (administration & dosage, adverse effects, immunology)
  • Humans
  • Immunization, Secondary
  • Infant
  • Virosomes

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: